Showing results (341-350 of 408) with videos related to

Sort By:
Pageof 41
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Cell|November 10, 2020
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody ProductionYuezhou Chen, Adam Zuiani, Stephanie Fischinger, et al.
NPJ Vaccines|May 23, 2024
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapyBoris Julg, Kathryn E Stephenson, Frank Tomaka, et al.
Scientific Reports|October 26, 2022
Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half lifeBaoshan Zhang, Deepika Gollapudi, Jason Gorman, et al.
JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Annals of Internal Medicine|February 3, 2016
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized TrialLindsey R Baden, Etienne Karita, Gaudensia Mutua, et al.
Science Translational Medicine|September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challengeBoris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.
Science Translational Medicine|May 6, 2011
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in MonkeysNorman L Letvin, Srinivas S Rao, David C Montefiori, et al.
Journal of Virology|November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein BoostBenedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Pageof 41